Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities

By Boesch Cedric E.   Meyer Thomas   Waschke Lena   Merkel Susanne   Goehl Jonas   Hohenberger Werner   Knorr Christian  

International Journal of Hyperthermia, Vol. 26, Iss. 1, 2010-06 ,pp. : 16-20

Informa Healthcare

Access to resources Recommend Favorite

Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma

By Moller Mecker   Lewis James   Dessureault Sophie   Zager Jonathan  

International Journal of Hyperthermia, Vol. 24, Iss. 3, 2008-01 ,pp. : 275-289

Informa Healthcare

Access to resources Recommend Favorite

Does Increased Experience with Isolated Limb Infusion for Advanced Limb Melanoma Influence Outcome? A Comparison of Two Treatment Periods at a Single Institution

By Huismans Anna  

Annals of Surgical Oncology, Vol. 18, Iss. 7, 2011-07 ,pp. : 1877-1883

Springer Publishing Company

Access to resources Recommend Favorite

A Comparison of Dosimetric Methods in Isolated Limb Perfusion with Melphalan for Malignant Melanoma of the Lower Extremity

By Byrne D.S.   McKay A.J.   Blackie R.   MacKie R.M.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2082-2087

Elsevier

Access to resources Recommend Favorite

Isolated limb perfusion for malignant melanoma; possibly better results with high dose hyperthermia

By  

International Journal of Hyperthermia, Vol. 24, Iss. 7, 2008-01 ,pp. : 602-603

Informa Healthcare

Access to resources Recommend Favorite